Aptose Biosciences Inc.APS

Aptose Biosciences Inc. APS

$3.64  -0.83 | -2.47%  Volume: 60967  Market Closed Latest Trading Date: 9/13/2021 15:43:17

Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address the unmet clinical need in chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other hematologic malignancies.


Company Name:Aptose Biosciences Inc.

Price: $3.55

Previous Close:$3.64

Open Price$3.61

Daily High$3.71

Daily Low$3.54

Market Cap:242799947


Change Percentage: -2.47%

Last Traded Date:Monday, September 13, 2021 3:43 PM


52 Week High:$9.40

52 Week Low:$3.01


PE:No Data

Volume Average:33850

Stock Exchange:Toronto Stock Exchange